{"id":"W2794310103","doi":"10.1038/s41416-018-0045-6","title":"New opportunities for kinase drug repurposing and target discovery","year":2018,"lang":"en","type":"letter","venue":"British Journal of Cancer","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Ministry of Economic Development and Innovation; Deutschen Konsortium für Translationale Krebsforschung; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Novartis Pharma; Wellcome Trust; Genome Canada; Ontario Genomics; Pfizer","keywords":"Kinome; Drug repositioning; Repurposing; Drug discovery; Drug; Kinase; Drug action; Computational biology; Mode of action; Drug development; Pharmacology; Biology; Bioinformatics; Toxicology; Cell biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007365298,0.0007773038,0.001759046,0.0009397844,0.001307074,0.003457082,0.00187483,0.01682784,0.01003971],"category_scores_gemma":[0.01823991,0.0006659571,0.001747705,0.0007147401,0.004176479,0.008884723,0.003165415,0.02975205,0.008626923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00288213,"about_ca_system_score_gemma":0.001425062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002660293,"about_ca_topic_score_gemma":0.0007294801,"domain_scores_codex":[0.9945592,0.001446443,0.0005768702,0.0005948294,0.002333032,0.0004895809],"domain_scores_gemma":[0.9856572,0.008806972,0.0007676235,0.001175846,0.001618355,0.001974014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.000435521,0.0002611695,0.001250468,0.0005883838,0.0001002039,0.008578776,0.0002352174,0.0005324504,0.002578686,0.03650779,0.7452152,0.2037161],"study_design_scores_gemma":[0.0001924636,0.0001941896,0.0006273706,0.000258225,0.0000281159,0.006640655,0.0001628177,0.0007616722,0.0005360694,0.05946424,0.9310953,0.00003889875],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001169619,0.03915318,0.002923944,0.9326047,0.01868287,0.00003679948,0.00007439514,0.0001588059,0.005195679],"genre_scores_gemma":[0.01888777,0.05697035,0.006131961,0.6996269,0.2080024,0.0001846068,0.0002924977,0.000107317,0.009796155],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01682784,"threshold_uncertainty_score":0.03895187,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02264069874741526,"score_gpt":0.2829191022204114,"score_spread":0.2602784034729962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}